Prophase Labs (PRPH) Stock Price

Prophase Labs Price

NASDAQ·CLOSED
0.06USD+0.0040 (+6.45 %)
Market closed

Revenue at Prophase Labs has contracted by 10.3% per year over the past 19 years to 6.77 M USD. Earnings per share have grown at 8.7% per year over the last 17 years. For Prophase Labs, the net margin of -788.2% is down versus -14.5% a few years ago. At today's price the dividend yield works out to roughly 937.50%. The payout ratio is around 61% of earnings. The consensus 12-month price target for Prophase Labs is 18.87 USD, about 29,384.4% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus. Prophase Labs's share price has lost 98.2% over the last twelve months. The stock trades about 7% above its 52-week low.

Prophase Labs stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Prophase Labs over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Prophase Labs stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Prophase Labs's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Prophase Labs Stock Price History
DateProphase Labs Price
7/29/20260.06 USD
7/28/20260.06 USD
7/27/20260.06 USD
7/23/20260.06 USD
7/22/20260.06 USD
7/21/20260.07 USD
7/20/20260.07 USD
7/17/20260.07 USD
7/16/20260.07 USD
7/15/20260.06 USD
7/14/20260.07 USD
7/13/20260.07 USD
7/10/20260.08 USD
7/9/20260.08 USD
7/8/20260.08 USD
7/7/20260.09 USD
7/6/20260.07 USD
7/2/20260.08 USD
7/1/20260.08 USD
6/30/20260.09 USD
6/29/20260.09 USD
6/26/20260.10 USD
6/25/20260.09 USD
6/24/20260.10 USD
6/23/20260.11 USD
6/22/20260.08 USD
6/18/20260.08 USD
6/17/20260.08 USD
6/16/20260.08 USD
6/15/20260.09 USD
6/12/20260.08 USD
6/11/20260.09 USD
6/10/20260.10 USD
6/9/20260.10 USD
6/8/20260.10 USD
6/5/20260.11 USD
6/4/20260.13 USD
6/3/20260.14 USD
6/2/20260.14 USD
6/1/20260.12 USD
5/29/20260.10 USD
5/28/20260.10 USD
5/27/20260.10 USD
5/26/20260.09 USD
5/22/20260.11 USD
5/21/20260.09 USD
5/20/20260.10 USD
5/19/20260.10 USD
5/18/20260.11 USD
5/15/20260.11 USD
5/14/20260.10 USD
5/13/20260.12 USD
5/12/20260.13 USD
5/11/20260.13 USD
5/8/20260.12 USD
5/7/20260.12 USD
5/6/20260.14 USD
5/5/20260.15 USD
5/4/20260.15 USD
5/1/20260.14 USD
4/30/20260.13 USD
4/29/20260.14 USD
4/28/20260.13 USD
4/27/20260.14 USD
4/24/20260.13 USD
4/23/20260.11 USD
4/22/20260.12 USD
4/21/20260.12 USD
4/20/20260.10 USD
4/17/20260.10 USD
4/16/20260.11 USD
4/15/20260.15 USD
4/14/20260.14 USD
4/13/20260.13 USD
4/10/20260.11 USD
4/9/20260.10 USD
4/8/20260.08 USD
4/7/20260.09 USD
4/6/20260.08 USD
4/2/20260.09 USD
4/1/20260.10 USD
3/31/20260.09 USD
3/30/20260.08 USD
3/27/20260.07 USD
3/26/20260.07 USD
3/25/20260.08 USD
3/24/20260.10 USD
3/23/20260.09 USD
3/20/20260.09 USD
3/19/20260.08 USD
3/18/20260.09 USD
3/17/20260.09 USD
3/16/20260.13 USD
3/13/20260.14 USD
3/12/20260.14 USD
3/11/20260.15 USD
3/10/20260.14 USD
3/9/20260.14 USD
3/6/20260.14 USD
3/5/20260.14 USD
3/4/20260.15 USD
3/3/20260.15 USD
3/2/20260.15 USD
2/27/20260.15 USD
2/26/20260.16 USD
2/25/20260.15 USD
2/24/20260.15 USD
2/23/20260.15 USD
2/20/20260.16 USD
2/19/20260.16 USD
2/18/20260.18 USD
2/17/20260.18 USD
2/13/20260.16 USD
2/12/20260.16 USD
2/11/20260.17 USD
2/10/20260.17 USD
2/9/20260.18 USD
2/6/20260.15 USD
2/5/20260.14 USD
2/4/20260.14 USD
2/3/20260.16 USD
2/2/20260.17 USD
1/30/20260.16 USD
1/29/20260.17 USD
1/28/20260.16 USD
1/27/20260.22 USD
1/26/20260.21 USD
1/23/20260.26 USD
1/22/20260.21 USD
1/21/20260.14 USD
1/20/20260.15 USD
1/16/20260.16 USD
1/15/20260.17 USD
1/14/20260.18 USD
1/13/20260.20 USD
1/12/20260.19 USD
1/9/20260.20 USD
1/8/20260.20 USD
1/7/20260.21 USD
1/6/20260.25 USD
1/5/20260.28 USD
1/2/20260.36 USD
12/31/20250.45 USD
12/30/20250.45 USD
12/29/20250.45 USD
12/26/20250.52 USD
12/24/20250.62 USD
12/23/20250.69 USD
12/22/20250.97 USD
12/19/20250.90 USD
12/18/20251.05 USD
12/17/20251.05 USD
12/16/20251.15 USD
12/15/20251.13 USD
12/12/20251.15 USD
12/11/20251.38 USD
12/10/20251.45 USD
12/9/20251.49 USD
12/8/20251.38 USD
12/5/20251.30 USD
12/4/20251.40 USD
12/3/20251.35 USD
12/2/20251.41 USD
12/1/20251.93 USD
11/28/20252.09 USD
11/26/20251.81 USD
11/25/20251.80 USD
11/24/20251.80 USD
11/21/20251.89 USD
11/20/20251.92 USD
11/19/20252.34 USD
11/18/20252.58 USD
11/17/20252.65 USD
11/14/20252.80 USD
11/13/20252.52 USD
11/12/20252.68 USD
11/11/20252.72 USD
11/10/20252.79 USD
11/7/20252.83 USD
11/6/20252.79 USD
11/5/20252.98 USD
11/4/20252.92 USD
11/3/20253.25 USD
10/31/20253.64 USD
10/30/20253.70 USD
10/29/20253.77 USD
10/28/20253.86 USD
10/27/20253.76 USD
10/24/20253.90 USD
10/23/20253.50 USD
10/22/20254.06 USD
10/21/20255.11 USD
10/20/20255.29 USD
10/17/20255.00 USD
10/16/20254.86 USD
10/15/20254.72 USD
10/14/20255.26 USD
10/13/20255.11 USD
10/10/20255.30 USD
10/9/20255.12 USD
10/8/20255.15 USD
10/7/20256.08 USD
10/6/20255.95 USD
10/3/20255.60 USD
10/2/20255.47 USD
10/1/20255.15 USD
9/30/20254.58 USD
9/29/20254.38 USD
9/26/20254.40 USD
9/25/20254.28 USD
9/24/20254.35 USD
9/23/20254.47 USD
9/22/20254.50 USD
9/19/20253.90 USD
9/18/20254.18 USD
9/17/20254.22 USD
9/16/20254.34 USD
9/15/20254.30 USD
9/12/20254.30 USD
9/11/20255.15 USD
9/10/20254.90 USD
9/9/20255.15 USD
9/8/20253.80 USD
9/5/20253.50 USD
9/4/20253.56 USD
9/3/20253.59 USD
9/2/20253.30 USD
8/29/20253.40 USD
8/28/20253.47 USD
8/27/20253.29 USD
8/26/20253.43 USD
8/25/20253.36 USD
8/22/20253.30 USD
8/21/20253.35 USD
8/20/20253.30 USD
8/19/20253.13 USD
8/18/20253.34 USD
8/15/20253.50 USD
8/14/20253.33 USD
8/13/20253.27 USD
8/12/20253.54 USD
8/11/20252.82 USD
8/8/20253.10 USD
8/7/20253.26 USD
8/6/20253.17 USD
8/5/20253.08 USD
8/4/20253.10 USD
8/1/20253.30 USD
7/31/20253.60 USD
Access this data via the Eulerpool API
Get Free API Key

Prophase Labs Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
9.90 M USD
-3.20 M USD
-3.10 M USD
Jan 1, 2020
14.50 M USD
-4.00 M USD
-2.10 M USD
Jan 1, 2021
79.00 M USD
9.80 M USD
6.30 M USD
Jan 1, 2022
122.60 M USD
23.60 M USD
18.50 M USD
Jan 1, 2023
34.98 M USD
-21.22 M USD
-16.78 M USD
Jan 1, 2024
6.77 M USD
-38.63 M USD
-53.36 M USD
Jan 1, 2025 (e)
21.79 M USD
-10.50 M USD
-1.17 M USD
Jan 1, 2026 (e)
47.32 M USD
119.05 M USD
8.27 M USD

Prophase Labs Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 31, 2026, 1:35 PM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
201120122013201420152016201720182019202020212022202320242025e2026e
17.0022.0025.0022.002.004.009.0013.009.0014.0079.00122.0034.006.0021.0047.00
21.4329.4113.64-12.00-90.91100.00125.0044.44-30.7755.56464.2954.43-72.13-82.35250.00123.81
64.7163.6464.0063.64750.0025.0011.1130.7722.2228.5753.1657.3844.12250.0044.1244.12
11.0014.0016.0014.0015.001.001.004.002.004.0042.0070.0015.0015.009.2620.74
-2.00-2.00–-4.00-2.00-3.00-4.00-1.00-3.00-4.009.0023.00-21.00-38.00-10.00119.00
-11.76-9.09–-18.18-100.00-75.00-44.44-7.69-33.33-28.5711.3918.85-61.76-633.33-47.62253.19
-2.00-1.00–-7.00-3.00-2.0040.00-1.00-3.00-2.006.0018.00-16.00-53.00-1.008.00
-33.33-50.00––-57.14-33.33-2,100.00-102.50200.00-33.33-400.00200.00-188.89231.25-98.11-900.00
1.481.481.631.681.641.711.561.141.161.161.841.871.722.052.052.05
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Prophase Labs generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Prophase Labs retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Prophase Labs's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Prophase Labs has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Prophase Labs's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Prophase Labs stock margins

The Prophase Labs margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Prophase Labs. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Prophase Labs.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
26.26 %
-32.32 %
-31.31 %
Jan 1, 2020
31.72 %
-27.59 %
-14.48 %
Jan 1, 2021
53.16 %
12.41 %
7.97 %
Jan 1, 2022
57.67 %
19.25 %
15.09 %
Jan 1, 2023
44.47 %
-60.66 %
-47.97 %
Jan 1, 2024
-2.22 %
-570.59 %
-788.24 %
Jan 1, 2025 (e)
-2.22 %
-48.18 %
-5.36 %
Jan 1, 2026 (e)
-2.22 %
251.60 %
17.48 %

Prophase Labs Stock Revenue, EBIT, Earnings per Share

The Prophase Labs earnings per share therefore indicates how much revenue Prophase Labs has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2019
85.61 USD
-27.67 USD
-26.81 USD
Jan 1, 2020
125.05 USD
-34.50 USD
-18.11 USD
Jan 1, 2021
429.51 USD
53.28 USD
34.25 USD
Jan 1, 2022
657.34 USD
126.53 USD
99.19 USD
Jan 1, 2023
203.31 USD
-123.32 USD
-97.53 USD
Jan 1, 2024
33.08 USD
-188.77 USD
-260.78 USD
Jan 1, 2025 (e)
106.47 USD
-51.30 USD
-5.71 USD
Jan 1, 2026 (e)
231.24 USD
581.78 USD
40.42 USD

Prophase Labs business model & stock analysis

Prophase Labs Segments

Prophase Labs Revenue by Segment (1/3)

  • 3 Years

  • 5 Years

  • Max

Consumer Products
Diagnostic Services
Details
Date
Consumer Products
Diagnostic Services
Jan 1, 2020
13.20 M USD
1.30 M USD
Jan 1, 2021
0.00 USD
0.00 USD
Jan 1, 2022
0.00 USD
0.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
Jan 1, 2024
0.00 USD
0.00 USD

Prophase Labs Revenue by Segment (2/3)

  • Max

Diagnostic services
Details
Date
Diagnostic services
Jan 1, 2020
0.00 USD
Jan 1, 2021
0.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
24.85 M USD
Jan 1, 2024
0.00 USD

Prophase Labs Revenue by Segment (3/3)

  • 3 Years

  • 5 Years

  • Max

Diagnostic services
Consumer products
Details
Date
Diagnostic services
Consumer products
Jan 1, 2020
1.28 M USD
13.24 M USD
Jan 1, 2021
68.56 M USD
10.48 M USD
Jan 1, 2022
108.33 M USD
14.32 M USD
Jan 1, 2023
0.00 USD
19.54 M USD
Jan 1, 2024
0.00 USD
6.77 M USD

Prophase Labs Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Prophase Labs historical P/E ratio, EBIT multiple, and P/S ratio

Prophase Labs annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Prophase Labs shares outstanding

The number of shares of Prophase Labs was 204,630 in 2025. This indicates how many shares Prophase Labs is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2019
115,640.00 Stocks
Jan 1, 2020
115,950.00 Stocks
Jan 1, 2021
183,930.00 Stocks
Jan 1, 2022
186,510.00 Stocks
Jan 1, 2023
172,070.00 Stocks
Jan 1, 2024
204,630.00 Stocks
Jan 1, 2025 (e)
204,630.00 Stocks
Jan 1, 2026 (e)
204,630.00 Stocks

Prophase Labs stock splits

In Prophase Labs's history, there have been no stock splits.

Prophase Labs Dividend History

4 years of dividend payments

YearAnnual DividendYoY ChangePayments
20220.60USD↑ 100.0%2×
20210.30USD↓ 40.0%1×
20190.50USD↓ 75.0%2×
20182.00USD—2×

Prophase Labs dividend payout ratio

In 2025, Prophase Labs had a payout ratio of 69.60%. The payout ratio indicates the percentage of the company's profits that Prophase Labs distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2019
-186.57 %
Jan 1, 2020
74.13 %
Jan 1, 2021
87.72 %
Jan 1, 2022
60.54 %
Jan 1, 2023
74.13 %
Jan 1, 2024
74.13 %
Jan 1, 2025 (e)
69.60 %
Jan 1, 2026 (e)
72.62 %

Current Prophase Labs forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy85.71 % (6)
Hold14.29 % (1)
Sell0.00 % (0)
12M Price Target
18.87
Last Price
0.06
Currency
USD
12M Return Potential
29,384.37 %
LTM Return
0 %

Prophase Labs Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
3/30/2026-0.12USD9.86 MUSD2025 Q4
11/17/2025-0.11USD5.80 MUSD2025 Q3
11/7/20240.04USD24.33 MUSD2024 Q3
5/9/2024-0.17USD15.48 MUSD2024 Q1
3/26/2024-0.27USD10.90 MUSD2023 Q4
11/10/20220.19USD21.75 MUSD2022 Q3
8/11/20220.18USD20.31 MUSD2022 Q2
5/13/20220.39USD24.68 MUSD2022 Q1
3/30/20220.45USD29.04 MUSD2021 Q4
11/12/20210.07USD9.21 MUSD2021 Q3

Prophase Labs shareholder structure

% Name
157.12892%
Karkus (Ted William)
Karkus (Ted William)
31.51029%
Sykon Capital LLC
Sykon Capital LLC
19.95147%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
12.66007%
Geode Capital Management, L.L.C.
Geode Capital Management, L.L.C.
11.21312%
Hightower Advisors, LLC
Hightower Advisors, LLC
10.65958%
Quinn Opportunity Partners LLC
Quinn Opportunity Partners LLC
...

Prophase Labs Executives and Management Board

TK

Mr. Ted Karkus

(65)

Chairman of the Board, Chief Executive Officer · since 2009

Compensation2.12 M USD
LG

Dr. Louis Gleckel

(69)

Independent Director

Compensation189,250.00 USD
WH

Mr. Warren Hirsch

(67)

Independent Director

Compensation189,250.00 USD
SP

Mr. Steven Plumb

(64)

Fractional Chief Financial Officer

CA

Ms. Carolina Abenante

(55)

Independent Director

Frequently asked questions about Prophase Labs

Analysts currently set an average price target of 18.87 USD for the Prophase Labs stock (median: 18.87 USD), implying +29,384.4 % versus the latest price. The consensus is based on 7 analyst ratings.

Prophase Labs Analyst Price Targets 2026

All fundamentals and in-depth analysis of Prophase Labs

Our stock analysis for Prophase Labs stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Prophase Labs. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Prophase Labs Stock
Prophase Labs Revenue→
Prophase Labs Stock
Prophase Labs Net Income→
Prophase Labs Stock
Prophase Labs P/E→
Prophase Labs Stock
Prophase Labs P/S→
Prophase Labs Stock
Prophase Labs EBIT→
Prophase Labs Stock
Prophase Labs Dividend→
Prophase Labs Stock
Prophase Labs Directors Dealings→
Prophase Labs Stock
Prophase Labs Stocks→
Prophase Labs Stock
Prophase Labs Market capitalization→
Prophase Labs Stock
Prophase Labs Debt→
Prophase Labs Stock
Prophase Labs Liabilities→
Prophase Labs Stock
Prophase Labs Equity→
Prophase Labs Stock
Prophase Labs AAQS→
Prophase Labs Stock
Prophase Labs Employees→
Prophase Labs Stock
Prophase Labs ROE→
Prophase Labs Stock
Prophase Labs ROA→
Prophase Labs Stock
Prophase Labs ROCE→
Prophase Labs Stock
Prophase Labs News→
Prophase Labs Stock
Prophase Labs Analyst Price Targets→

Health Stocks

ProQR TherapeuticsPropanc BiopharmaProstatype GenomicsPromisia HealthcareProtagenic TherapeuticsProMIS NeurosciencesProtagonist TherapeuticsPromimicProtalix BiotherapeuticsProkidneyProtara TherapeuticsProgynyAll Stocks A–Z →